Pfiz­er reshuf­fles top ranks with Al­bert Bourla as COO; In­tra-cel­lu­lar nabs No­var­tis vet An­drew Satlin as CMO

Pfiz­er has pro­mot­ed its In­no­v­a­tive Health chief Al­bert Bourla to the new role of chief op­er­at­ing of­fi­cer, where he’s been giv­en a spe­cial man­date to over­see the day-to-day ac­tiv­i­ty around prod­uct de­vel­op­ment, sales and strat­e­gy. This has been in­ter­pret­ed as CEO Ian Read’s way of anoint­ing his suc­ces­sor, al­though that is far from cer­tain. The move, which be­comes of­fi­cial on Jan­u­ary 1, trig­gered a reshuf­fle in the top ranks at Pfiz­er. John Young, who heads Pfiz­er Es­sen­tial Health, takes Bourla’s old job, while An­gela Hwang suc­ceeds Young.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.